Fig. 2. Selection of features for type 2 diabetes mellitus prediction model generation using ‘Information Gain Attribute Evaluation.’ CAD, coronary artery disease; CKD-MDRD, chronic kidney disease–the modification of diet in renal disease; PCI, percutaneous coronary intervention; ARB, angiotensin receptor blockers; ACEI, angiotensin-converting enzyme inhibitors; CCB, calcium channel blockers; DHP, dihydropyridine; BB, beta blockers.
